BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Huang Z, Su Y, Zhang T, Xia N. A review of the safety and efficacy of current COVID-19 vaccines. Front Med 2022. [PMID: 35122210 DOI: 10.1007/s11684-021-0893-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Tanriover MD, Aydin OA, Guner R, Yildiz O, Celik I, Doganay HL, Kose S, Akhan S, Akalin EH, Sezer Z, Ozdarendeli A, Unal S, on behalf of the TURKOVAC Study Group. Efficacy, Immunogenicity, and Safety of the Two-Dose Schedules of TURKOVAC versus CoronaVac in Healthy Subjects: A Randomized, Observer-Blinded, Non-Inferiority Phase III Trial. Vaccines 2022;10:1865. [DOI: 10.3390/vaccines10111865] [Reference Citation Analysis]
2 Abdul Aziz NI, Flanders S, Nungsari M. Social expectations and government incentives in Malaysia’s COVID-19 vaccine uptake. PLoS ONE 2022;17:e0275010. [DOI: 10.1371/journal.pone.0275010] [Reference Citation Analysis]
3 Fadul A, Abdalla E, Abdelmahmuod E, Abdulgayoom M, Ali E, Al-warqi A, Al-yahary H. COVID-19 Vaccine-Induced Cerebral Sinus Thrombosis: Coincidence vs. Cause? Cureus 2022. [DOI: 10.7759/cureus.26436] [Reference Citation Analysis]
4 Dong C, Yu Z, Quan X, Wei S, Wang J, Ma X. No Differences in Wound Healing and Scar Formation Were Observed in Patients With Different COVID-19 Vaccination Intervals. Front Public Health 2022;10:883113. [PMID: 35719612 DOI: 10.3389/fpubh.2022.883113] [Reference Citation Analysis]
5 Liu Y, Li L, Timani KA, He JJ. A Unique Robust Dual-Promoter-Driven and Dual-Reporter-Expressing SARS-CoV-2 Replicon: Construction and Characterization. Viruses 2022;14:974. [DOI: 10.3390/v14050974] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Machado BAS, Hodel KVS, Fonseca LMDS, Pires VC, Mascarenhas LAB, da Silva Andrade LPC, Moret MA, Badaró R. The Importance of Vaccination in the Context of the COVID-19 Pandemic: A Brief Update Regarding the Use of Vaccines. Vaccines 2022;10:591. [DOI: 10.3390/vaccines10040591] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]